Eli Lilly's bimagrumab led to weight loss that was due almost entirely to fat reduction when combined with semaglutide, ...

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

Initiative aims to expand and encourage philanthropy to help patients with retinal diseases afford their medicationsTARRYTOWN, N.Y., June 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.

Retirement Systems of Alabama made a bold financial move by increasing its stake in Regeneron Pharmaceuticals by a whopping ...

The combination offers a potential solution to one of the key problems that’s emerged with popular obesity shots.

UBS has decided Regeneron Pharmaceuticals needs a new wardrobe, trimming its price target from $633 to a more modest $560.

The combination of once-weekly cagrilintide 2.4 mg and semaglutide 2.4 mg conferred greater weight loss at 68 weeks compared ...

An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in patients with ...

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

As the global weight-loss market explodes, drugmakers are now racing to solve a less visible problem: protecting muscle mass ...

Regeneron Pharmaceuticals REGN has outperformed the market over the past 20 years by 14.22% on an annualized basis producing an average annual return of 22.54%. Currently, Regeneron Pharmaceuticals ...

Analysts have projected that obesity drugs sales could reach $150 billion a year by the early 2030s. The unmet need to ...